Please Note:
This profile was automatically generated using 1 reference found on the Internet. This information has not been verified. Learn more...
This profile was automatically generated using 1 reference found on the Internet. This information has not been verified. Learn more...
Web References
-
1. Untitled Document
www.chce.net/ondemand/lifeline - [Cached]Published on: 7/3/2002 Last Visited: 3/7/2003
Thomas D. Anderson, LPN, BSPharm, PharmD Director of Clinical Pharmacy Services
...
Thomas D. Anderson, LPN, BSPharm, PharmD, is the Director of Clinical Pharmacy Services at Mercy General Health Partners in Muskegon, Michigan. He is also Adjunct Assistant Professor of Clinical Pharmacy at the Ferris State University College of Pharmacy in Big Rapids, Michigan.
After earning his nursing degree from the Mercy School of Practical Nursing in Cadillac, Michigan, Dr. Anderson obtained his bachelor of science and doctorate degrees in pharmacy from Ferris State University. Dr. Anderson's clinical rotation experience included oncology, infectious diseases, internal medicine, critical care medicine, ambulatory care medicine, and nutrition. He is a licensed practical nurse and a registered pharmacist in the state of Michigan.
Dr. Anderson is a member of the American Society of Health-System Pharmacists and the Michigan Pharmacists Association and has chaired the Professional Affairs Committee of the Michigan Pharmacists Association since 1996. He has written articles for the journal New Developments in Vascular Diseases and has presented on such topics as thrombolytic options for the management of vascular access device occlusions, thrombolytics and GPIIb/IIIa inhibitors in peripheral artery occlusions, cardiovascular pharmacotherapy, dyslipidemia treatment guidelines, and the pathophysiology and pharmacotherapy of depression. Among other responsibilities, Dr. Anderson coordinates Institutional Review Board activity at Mercy General Health Partners. He has served as a principal investigator on clinical trials and has coordinated activities for thrombolytic trials in the periphery.
